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Summary. In population studies on the etiology of disease, one goal is the estimation of
the fraction of cases attributable to each of several causes. For example, pneumonia is a
clinical diagnosis of lung infection that may be caused by viral, bacterial, fungal, or other
pathogens. The study of pneumonia etiology is challenging because directly sampling from
the lung to identify the etiologic pathogen is not standard clinical practice in most settings. In-
stead, measurements from multiple peripheral specimens are made. This paper introduces
the statistical methodology designed for estimating the population etiology distribution and
the individual etiology probabilities in the Pneumonia Etiology Research for Child Health
(PERCH) study of 9, 500 children for 7 sites around the world. We formulate the scientific
problem in statistical terms as estimating the mixing weights and latent class indicators un-
der a partially-latent class model (pLCM) that combines heterogeneous measurements with
different error rates obtained from a case-control study. We introduce the pLCM as an ex-
tension of the latent class model. We also introduce graphical displays of the population
data and inferred latent-class frequencies. The methods are tested with simulated data, and
then applied to PERCH data. The paper closes with a brief description of extensions of the
pLCM to the regression setting and to the case where conditional independence among the
measures is relaxed.
Keywords: Bayesian method; Case-control; Etiology; Latent class; Measurement er-
ror; Pneumonia
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1. Introduction
Identifying the pathogens responsible for infectious diseases in a population poses signifi-
cant statistical challenges. Consider the measurement problem in the Pneumonia Etiology
Research for Child Health (PERCH), a case-control study that has enrolled 9, 500 children
from 7 sites around the world. Pneumonia is a clinical syndrome that develops because of
an infection of the lung tissue by bacteria, viruses, mycobacteria or fungi (Levine et al.,
2012). The appropriate treatment and public health control measures vary by pathogen.
Which pathogen is infecting the lung usually cannot be directly observed and must there-
fore be inferred from multiple peripheral measurements with differing error rates. The
primary goals of the PERCH study are to integrate the multiple sources of data to: (1) at-
tribute a particular case’s lung infection to a pathogen, and (2) estimate the prevalences of
the etiologic pathogens in a population of children that met clinical pneumonia definitions.
The basic statistical framework of the problem is pictured in Figure 1. The disease
status is determined by clinical examination including chest X-ray (Deloria-Knoll et al.,
2012). The known pneumonia status (case-control) is directly caused by the presence
or absence of a pathogen-caused infection in the lung. For controls, the lung is known
to be sterile and has no infection. For a child clinically diagnosed with pneumonia, the
pathogen causes the infection in a child’s lung is the scientific target of interest. Among the
candidate pathogens being tested, we assume only one is the primary cause. Extensions
to multiple pathogens are straightforward. Because, for most cases, it is not possible to
directly sample the lung, we do not know with certainty which pathogen infected the lung,
so we seek to infer the infection status based upon a series of laboratory measurements of
specimens from various body fluids and body sources.
PERCH was originally designed with three sources of measurements relevant to the
lung infection: directly from the lung by lung aspirate; from blood culture; and from the
nasopharyngeal cavity (by swab). Therefore, our model was designed to accommodate all
three sources. As the study progressed, less than 1% of cases had direct lung measurements
and this sampled group was unrepresentative of all cases. The model and software here
include all three sources of measurements for application to other etiology studies, but the
analysis of the motivating PERCH data below uses only blood culture and nasopharyngeal
swab data.
The measurement error rates differ by type of measurement. Here, an error rate or
epidemiologic error rate is the probability of the pathogen’s presence/absence in a specimen
test given presence/absence of infection in the lung. For this application, it is convenient
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to categorize measures into three subgroups referred to as “gold”, “silver”, and “bronze”
standard measurements. A gold-standard (GS) measurement is assumed to have both
perfect sensitivity and specificity. Lung aspirate data would have been gold-standard. A
silver-standard (SS) measurement is assumed to have perfect specificity, but imperfect
sensitivity. Culturing bacteria from blood samples (B-cX) is an example of silver-standard
measurements in PERCH. Finally, bronze-standard (BrS) measurements are assumed to
have imperfect sensitivity and specificity. Polymerase chain reaction (PCR) evaluation of
bacteria and viruses from nasopharyngeal samples is an example.
In the PERCH study, both SS and BrS measurements are available for all cases. BrS,
but not SS measures are available for controls. Our goal was to develop a statistical model
that combines GS and SS measurements from cases, with BrS data from cases and controls
to estimate the distribution of pathogens in the population of pneumonia cases, and the
conditional probability that each of the J pathogens is the primary cause of an individual
child’s pneumonia given her or his set of measurements. Even in applications where GS
data is not available, a flexible modeling framework that can accommodate GS data is
useful for both the evaluation of statistical information from BrS data (Section 3) and the
incorporation of GS data if it becomes available as measurement technology improves.
Latent class models (LCM) (Goodman, 1974) have been successfully used to integrate
multiple diagnostic tests or raters’ assessments to estimate a binary latent status for all
study subjects (Hui and Walter, 1980; Qu and Hadgu, 1998; Albert et al., 2001; Albert
and Dodd, 2008). In the LCM framework, conditional distributions of measurements given
latent status are specified. Then the marginal likelihood of the multivariate measurements
are maximized as a function of the disease prevalence, sensitivities and specificities. This
framework has also been extended to infer ordinal latent status (Wang et al., 2011).
There are three salient features of the PERCH childhood pneumonia problem that
require extension of the typical LCM approach. First, we have partial knowledge of the
latent lung state for some subjects as a result of the case-control design. In the standard
LCM approach, the study population comprises subjects with completely unknown class
membership. In this study, controls are known to have no pathogen infecting the lung.
Also, were gold standard measurements available from the lung for some cases, their latent
variable would be directly observed. As the latent state is known for a non-trivial subset of
the study population, we refer to this model as a partially-Latent Class Model or pLCM.
Second, in most LCM applications, the number of observed measurements on a subject
is much larger than the number of latent state categories. Here, the number of observations
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is of the same order as the number of categories that the latent status can assume. For
example, if we consider only the PERCH study BrS data, we simultaneously observe the
presence/absence of each member from a list of possible pathogens for each child. Even
with additional control data, the larger number of latent categories of latent status leads
to weak model identifiability as is discussed in more detail in Section 2.1.
Lastly, measurements with differing error rates (i.e. GS, SS, BrS) need to be integrated.
Note that the modeling framework introduced here is general and can be applied to studies
where multiple BrS measurements are available, each with a different set of error rates.
Understanding the relative value of each level of measurements is important to optimally
invest resources into data collection (number of subjects, type of samples) and laboratory
assays. An important goal is therefore to estimate the relative information from each type
of measurements about the population and individual etiology distributions.
Albert and Dodd (2008) studied a model where some subjects are selected to verify
their latent status (i.e. collect GS measurements) with the probability of verification
either depending on the previous test results or being completely at random. They showed
GS data can make model estimates more robust to model misspecifications. We further
quantify how much GS data reduces the variance of model parameter estimates for design
purposes. Also, they considered binary latent status and did not have available control
data. Another related literature that uses both GS and BrS data is on verbal autopsy (VA)
in the setting where no complete vital registry system is established in the community
(King and Lu, 2008). Quite similar to the goal of inferring pneumonia etiology from lab
measurements, the VA goal is to infer the cause of death from a pre-specified list by asking
close family members questions about the presence/absence of several symptoms. King
and Lu (2008) proposed estimating the cause-of-death distribution in a community using
data on dichotomous symptoms and GS data from the hospital where cause-of-death and
symptoms are both recorded. However, their method involves nonparametric and requires
a sizable sample of GS data, especially when the number of symptoms is large. In addition,
a key difference between VA and most infectious disease etiology studies is that the VA
studies are by definition case-only.
Another approach previously used with case and control data is to perform logistic
regression of case status on laboratory measurements and then to calculate point estimates
of population attributable risks for each pathogen (Bruzzi et al., 1985; Blackwelder et al.,
2012). This method does not account for imperfect laboratory measurements and cannot
use GS or SS data if available. Also, the population attributable fraction method assigns
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zero etiology for the subset of pathogens that have estimated odds ratios smaller than 1,
without taking account of the statistical uncertainty for the odds ratio estimates.
In this paper, we define and apply a partially-latent class model (pLCM) to incorpo-
rate these three features: known infection status for controls; a large number of latent
classes; and multiple types of measurements. We use a hierarchical Bayesian formulation
to estimate: (1) the population etiology distribution or etiology fraction —the frequency
with which each pathogen “causes” clinical pneumonia in the case population; and (2) the
individual etiology probabilities—the probabilities that a case is “caused” by each of the
candidate pathogens, given observed specimen measurements for that individual.
In Section 4, to facilitate communications with scientists, we introduce graphical dis-
plays that put data, model assumptions, and results together. They enable the scientific
investigators to better understand the various sources of evidence from data and their
contribution to the final etiology estimates.
The remainder of this paper proceeds as follows. In section 2, we formulate the pLCM
and the Gibbs sampling algorithms for implementation. In Section 3, we evaluate our
method through simulations tailored for the childhood pneumonia etiology study. Section
4 presents the analysis of PERCH data. Lastly, Section 5 concludes with a discussion
of results and limitations, a few natural extensions of the pLCM also motivated by the
PERCH data, as well as future directions of research.
2. A partially-latent class model for multiple indirect measurements
We develop pLCM to address two characteristics of the motivating pneumonia problem: (1)
a partially-latent state variable because the pathogen infection status is known for controls
but not cases; and (2) multiple categories of measurements with different error rates across
classes. As shown in Figure 1, let ILi , taking values in {0, 1, 2, ...J}, represent the true
state of child i’s lung (i = 1, ..., N) where 0 represents no infection (control) and ILi = j,
j = 1, ..., J , represents the jth pathogen from a pre-specified cause-of-pneumonia list that
is assumed to be exhaustive. ILi is the scientific target of inference for individual diagnosis.
Let MSi represent the J × 1 vector of binary indicators of the presence/absence of each
pathogen in the measurement at site S, where, in our childhood pneumonia etiology study
S can be nasopharyngeal (NP), blood (B), or lung (L). Let mSi be the actual observed
values. In the following, we replace S with BrS, SS, or GS, because they correspond to
the measurement types at NP, B, and L, respectively.
Let Yi = yi ∈ {0, 1} represent the indicator of whether child i is a healthy control or a
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clinically diagnosed case. Note ILi = 0 given Yi = 0. To formalize the pLCM, we define
three sets of parameters:
• pi = (pi1, ..., piJ)′ , the vector of compositional probabilities for each of J pathogen
causes, that is, Pr(ILi = j | Yi = 1,pi), j = 1, ..., J ;
• ψSj = Pr(MSij = 1|ILi = 0), the false positive rate (FPR) for measurement j (j =
1, ..., J) at site S. Note that The FPRs {ψSj }Jj=1 can be estimated from the control
data at site S, because ILi = 0 denotes that the ith subject has no infection in the
lung, i.e. a control;
• θSj = Pr(MSij = 1|ILi = j), the true positive rate (TPR) for measurement j at site S
for a person whose lung is infected by pathogen j, j = 1, ...J .
We further let ψS = (ψS1 , ..., ψ
S
J )
′ and θS = (θS1 , ..., θSJ )
′. Using these definitions, we have
FPR ψGSj = 0 and TPR θ
GS
j = 1 for GS measurements, so that M
GS
ij = 1 if and only
if ILi = j, j = 1, ..., J (perfect sensitivity and specificity). For SS measurements, FPR
ψSSj = 0 so that M
SS
j = 0 if I
L
i 6= j (perfect specificity).
We formalize the model likelihood for each type of measurement. We first describe the
model for BrS measurement MBrS for a control or a case. For control i, positive detection
of the jth pathogen is a false positive representation of the non-infected lung. Therefore,
we assume MBrSij | ψBrS ∼ Bernoulli(ψSj ), j = 1, ..., J , with conditional independence, or
equivalently,
P 0,BrSi = Pr(M
BrS
i = m | ψBrS ) =
J∏
j=1
(
ψBrSj
)mj (
1− ψBrSj
)1−mj
, (1)
where m = mBrSi . For a case infected by pathogen j, the positive detection rate for the
jth pathogen in BrS assays is θBrSj . Since we assume a single cause for each case, detection
of pathogens other than j will be false positives with probability equal to FPR as in
controls: ψBrSl , l 6= j. This nondifferential misclassification across the case and control
populations is the essential assumption of the latent class approach because it allows us to
borrow information from control BrS data to distinguish the true cause from background
colonization. We further discuss it in the context of the pneumonia etiology problem in
the final section. Then,
P 1,BrSi = Pr(M
BrS
i = m | pi,θBrS ,ψBrS )
=
J∑
j=1
pij ·
(
θBrSj
)mj (
1− θBrSj
)1−mj∏
l 6=j
(
ψBrSl
)ml (
1− ψBrSl
)1−ml
, (2)
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is the likelihood contributed by BrS measurements from case i, where m = mBrSi .
Similarly, likelihood contribution from case i’s SS measurements can be written as
P 1,SSi = Pr(M
SS
i = m | pi,θSS ) =
J ′∑
j=1
pij ·
(
θSSj
)mj
(1− θSSj )1−mj1{∑J′l=1ml≤1}, (3)
for m = mSSi , noting the perfect specificity of SS measurements, where J
′ ≤ J represents
the number of actual SS measurements on each case, and θSS =
(
θSS1 , ...θ
SS
J ′
)
. SS measure-
ments only test for a subset of all J pathogens, e.g., blood culture only detects bacteria
and J ′ is the number of bacteria that are potential causes. Finally, for completeness, GS
measurement is assumed to follow a multinomial distribution with likelihood:
P 1,GSi = Pr
(
MGSi = m | pi
)
=
J∏
j=1
pi
1{mj=1}
j 1{∑jmj=1}, (4)
where m = mGSi , and 1{·} is the indicator function and equals one if the statement in {·}
is true; otherwise, zero.
Let δi be the binary indicator of a case i having GS measurements; it equals 1 if the
case has available GS data and 0 otherwise. Combining likelihood components (1)—(4),
the total model likelihood for BrS, SS, and GS data across independent cases and controls
is
L(γ;D) =
∏
i:Yi=0
P 0,BrSi
∏
i:Yi=1,δi=1
P 1,BrSi · P 1,SSi · P 1,GSi
∏
i:Yi=1,δi=0
P 1,BrSi · P 1,SSi , (5)
where γ = (θBrS ,ψBrS ,θSS ,pi)′ stacks all unknown parameters, and data D is{{
mBrSi
}
i:Yi=0
}
∪
{{
mBrSi ,m
GS
i ,m
SS
i
}
i:Yi=1,δi=1
}
∪
{{
mBrSi′′ ,m
SS
i′′
}
i′′ :Y
i
′′=1,δ
i
′′=0
}
collects all the available measurements on study subjects. Our primary statistical goal
is to estimate the posterior distribution of the population etiology distribution pi, and to
obtain individual etiology (IL∗ ) prediction given a case’s measurements.
To enable Bayesian inference, prior distributions on model parameters are specified as
follows: pi ∼ Dirichlet(a1, . . . , aJ), ψBrSj ∼ Beta(b1j , b2j), θBrSj ∼ Beta(c1j , c2j), j = 1, ..., J ,
and θSSj ∼ Beta(d1j , d2j), j = 1, ..., J ′. Hyperparameters for etiology prior, a1, ..., aJ , are
usually 1s to denote equal and non-informative prior weights for each pathogen if expert
prior knowledge is unavailable. The FPR for the jth pathogen, ψBrSj , generally can be well
estimated from control data, thus b1j = b2j = 1 is the default choice. For TPR parameters
θBrSj and θ
SS
j , if prior knowledge on TPRs is available, we choose (c1j , c2j) so that the
2.5% and 97.5% quantiles of Beta distribution with parameter (c1j , c2j) match the prior
minimum and maximum TPR values elicited from pneumonia experts . Otherwise, we
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use default value 1s for the Beta hyperparameters. Similarly we choose values of (d1j , d2j)
either by prior knowledge or default values of 1. We finally assume prior independence
of the parameters as [γ] = [pi][ψBrS ][θBrS ][θSS ], where [A] represents the distribution of
random variable or vector A. These priors represent a balance between explicit prior
knowledge about measurement error rates and the desire to be as objective as possible for
a particular study. As described in the next section, the identifiability constraints on the
pLCM require specifying a reasonable subset of parameter values to identify parameters
of greatest scientific interest.
2.1. Model identifiability
Potential non-identifiability of LCM parameters is well-known (Goodman, 1974). For
example, an LCM with four observed binary indicators and three latent classes is not
identifiable despite providing 15 degree-of-freedom to estimate 14 parameters (Goodman,
1974). In principle, the Bayesian framework avoids the non-identifiability problem in
LCMs by incorporating prior information about unidentified parameter subspaces (e.g.,
Garrett and Zeger (2000)). Many authors point out that the posterior variance for non-
identifiable parameters does not decrease to zero as sample size approaches infinity (e.g.,
Kadane (1974); Gustafson et al. (2001); Gustafson (2005)). Even when data are not fully
informative about a parameter, an identified set of parameter values consistent with the
observed data shall, can nevertheless, be valuable in a complex scientific investigation
(Gustafson, 2009) like PERCH.
When GS data is available, the pLCM is identifiable; when it is not, the two sets
of parameters, pi and {θBrSj }Jj=1 are not both identified and prior knowledge must be
incorporated. Here we restrict attention to the scenario with only BrS data for simplicity
but similar arguments pertain to the BrS + SS scenario. The problem can be understood
from the form of the positive measurement rates for pathogens among cases. In the pLCM
likelihood for the BrS data (only retaining components in (5) with superscripts BrS ), the
positive rate for pathogen j is a convex combination of the TPR and FPR:
Pr
(
MBrSij = 1 | pij , θBrSj , ψBrSj
)
= pijθ
BrS
j + (1− pij)ψBrSj , (6)
where the left-hand side of the above equation can be estimated by the observed positive
rate of pathogen j among cases. Although the control data provide ψBrSj estimates, the
two parameters, pij and θ
BrS
j , are not both identified. GS data, if available, identifies pij
and resolves the lack of identifiability. Otherwise, we need to incorporate prior scientific
information on one of them, usually the TPR (θBrSj ). In PERCH, prior knowledge about
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θBrSj is obtained from infectious disease and laboratory experts (Murdoch et al., 2012)
based upon vaccine probe studies (Cutts et al., 2005; Madhi et al., 2005). If the observed
case positive rate is much higher than the rate in controls (ψBrSj ), only large values of TPR
(θBrSj ) are supported by the data making etiology estimation more precise (Section 2.2).
The full model identification can be generally characterized by inspecting the Jacobian
matrix of the transformation F from model parameters γ to the distribution p of the ob-
servables, p = F (γ). Let γ = (θBrS ,ψBrS , pi1, ..., piJ−1)′ represent the 3J − 1-dimensional
unconstrained model parameters. The pLCM defines the transformation (p1,p0)
′ = F (γ),
where p1 and p0 are the two contingency probability distributions for the BrS measure-
ments in the case and control populations, each with dimension 2J − 1. It can be shown
that the Jacobian matrix has J − 1 of its singular values being zero, which means model
parameters γ are not fully identified from the data. The FPRs (ψBrSj , j = 1, ..., J) in pLCM
are, however, identifiable parameters that can be estimated from control data. Therefore,
pLCM is termed partially identifiable (Jones et al., 2010).
2.2. Parameter estimation and individual etiology prediction
The parameters in likelihood (5) include the population etiology distribution (pi), TPRs
and FPRs for BrS measurements (ψBrS and θBrS ), and TPRs for SS measurements (θSS ).
The posterior distribution of these parameters can be estimated by constructing approxi-
mating samples from the joint posterior via a Markov chain Monte Carlo (MCMC) Gibbs
sampler. The full conditional distributions for the Gibbs sampler are detailed in Section
A of the supplementary material.
We develop a Gibbs sampler with two essential steps:
(i) Multinomial sampling of lung infection state among cases:
ILi | pi, Yi = 1 ∼ Multinomial(pi);
(ii) Measurement stage given lung infection state:
MBrSij | ILi ,θBrS ,ψBrS ∼ Bernoulli
(
1{ILi =j}θ
BrS
j +
(
1− 1{ILi =j}
)
ψBrSj
)
, j = 1, ..., J ,
conditionally independent.
This is readily implemented using freely available software WinBUGS 1.4. In the ap-
plication below, convergence was monitored using auto-correlations, kernel density plots,
and Brooks-Gelman-Rubin statistics (Brooks and Gelman, 1998) of the MCMC chains.
The statistical results below are based on 10, 000 iterations of burn-in followed by 50, 000
production samples from each of three parallel chains.
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The Bayesian framework naturally allows individual within-sample classification (in-
fection diagnosis) and out-of-sample prediction. This section describes how we calculate
the etiology probabilities for an individual with measurements m∗. We focus on the more
challenging inference scenario when only BrS data are available; the general case follows
directly.
The within-sample classification for case i is based on the posterior distribution of
latent indicators given the observed data, i.e. Pr(ILi = j | D), j = 1, ..., J , which can be
obtained by averaging along the cause indicator (ILi ) chain from MCMC samples. For a
case with new BrS measurements m∗, we have
Pr(ILi = j |m∗,D) =
∫
Pr(ILi = j |m∗,γ) Pr(γ |m∗,D)dγ, j = 1, ...J, (7)
where the second factor in the integrand can be approximated by the posterior distribution
given current data, i.e., Pr(γ | D). For the first term in the integrand, we explicitly obtain
the model-based, one-sample conditional posterior distribution, Pr(ILi = j | m∗,γ) =
pij`j(m∗;γ)
/∑
m pirm`m(m∗;γ), j = 1, ..., J , where
`m(m∗;γ) =
(
θBrSj
)m∗j (
1− θBrSj
)1−m∗j∏
l 6=j
(
ψBrSl
)m∗l (
1− ψBrSl
)1−m∗l
is the mth mixture component likelihood function evaluated at m∗. The log relative
probability of ILi = j versus I
L
i = l is
Rjl = log
(
pij
pil
)
+ log

(
θBrSj
ψBrSj
)m∗j (
1− θBrSj
1− ψBrSj
)1−m∗j
+ log
{(
ψBrSl
θBrSl
)m∗l (1− ψBrSl
1− θBrSl
)1−m∗l}
.
The form of Rjl informs us about what is required for correct diagnosis of an individual.
Suppose ILi = j, then averaging over m∗, we have E[Rjl] = log (pij/pil) + I(θ
BrS
j ;ψ
BrS
j ) +
I(ψBrSl ; θ
BrS
l ), where I(v1; v2) = v1 log(v1/v2) + (1− v1) log ((1− v1)/(1− v2)) is the infor-
mation divergence (Kullback, 2012) that represents the expected amount of information
in m∗j ∼ Bernoulli(v1) for discriminating against m∗j ∼ Bernoulli(v2). If v1 = v2, then
I(v1; v2) = 0. The form of E[Rjl] shows that there is only additional information from BrS
data about an individual’s etiology in the person’s data when there is a difference between
θBrSj and ψ
BrS
j , j = 1, ..., J .
Following equation (7), we average Pr(ILi = j | m∗,γ) over MCMC iterations to
obtain individual prediction for the jth pathogen, pˆij , with γ replaced by its simulated
values γ∗ at each iteration. Repeating for j = 1, ..., J , we obtain a J probability vector,
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pˆi = (pˆi1, ..., pˆiJ)
′, that sums to one. This scheme is especially useful when a newly
examined case has a BrS measurement pattern not observed in D, which often occurs when
J is large. The final decisions regarding which pathogen to treat can then be based upon
pˆi. In particular, the pathogen with largest posterior value might be selected. It is Bayes
optimal under mean misclassification loss. Individual etiology predictions described here
generalize the positive/negative predictive value (PPV/NPV) from single to multivariate
binary measurements and can aid diagnosis of case subjects under other user-specified
misclassification loss functions.
3. Simulation for three pathogens case with GS and BrS data
To demonstrate the utility of the pLCM for studies like PERCH, we simulate BrS data
sets with 500 cases and 500 controls for three pathogens, A, B, and C using known
pLCM specifications. We focus on three states to facilitate viewing of the pi estimates
and individual predictions in the 3-dimensional simplex S2. We use the ternary dia-
gram (Aitchison, 1986) representation where the vector pi = (piA, piB, piC)
′ is encoded
as a point with each component being the perpendicular distance to one of the three
sides. The parameters involved are fixed at TPR = θ = (θA, θB, θC)
′ = (0.9, 0.9, 0.9)′,
FPR = ψ = (ψA, ψB, ψC)
′ = (0.6, 0.02, 0.05)′, and pi = (piA, piB, piC)′ = (0.67, 0.26, 0.07)′.
We focus on BrS and GS data here and have dropped the “BrS ” superscript on the pa-
rameters for simplicity. We further let the fraction of cases with GS measurements (∆)
be either 1% as in PERCH or 10%. Although GS measurements are rare in the PERCH
study, we investigate a large range of ∆ to understand in general how much statistical
information is contained in BrS measurements relative to GS measurements.
For any given data set, three distinct subsets of the data can be used: BrS-only, GS-only,
and BrS+GS, each producing its posterior mean of pi, and 95% credible region (Bayesian
confidence region) by transformed Gaussian kernel density estimator for compositional
data (Chaco´n et al., 2011). To study the relative importance of the GS and BrS data, the
primary quantity of interest in the simulations is the relative sizes of the credible regions
for each data mix. Here, we use uniform priors on θ, ψ, and Dirichlet(1, ..., 1) prior for pi.
The results are shown in Figure 2.
First, in Figures 2a (1% GS) and 2b (10% GS), each region covers the true etiology pi.
In data not shown here, the nominal 95% credible regions covers slightly more than 95%
of 200 simulations. Credible regions narrow in on the truth as we combine BrS and GS
data, and as the fraction of subjects with GS data (∆) increases. Also, the posterior mean
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from the BrS+GS analysis is an optimal balance of information contained in the GS and
BrS data.
Using the same simulated data sets, Figures 2c and 2d also show individual etiology
predictions for each of the 8(= 23) possible BrS measurements (mA,mB,mC)
′,mj = 0, 1,
obtained by the methods from Section 2.2. Consider the example of a newly enrolled
case without GS data and with no pathogen observed in her BrS data: m = (0, 0, 0)′.
Suppose she is part of a case population with 10% GS data. In the case illustrated in
Figure 2d, her posterior predictive distribution has highest posterior probability (0.76)
on pathogen A reflecting two competing forces: the FPRs that describe background colo-
nization (colonization among the controls) and the population etiology distribution. Given
other parameters, m = (0, 0, 0)′ gives the smallest likelihood for ILi = A because of its high
background colonization rate (FPR ψA = 0.6). However, prior to observing (0, 0, 0)
′, piA
is well estimated to be much larger than piB and piC . Therefore the posterior distribution
for this case is heavily weighted towards pathogen A.
Because it is rare to observe pathogen B in a case whose pneumonia is not caused by
B, for a case with observation (1, 1, 1)′, the prediction favors B. Although B is not the
most prevalent cause among cases, the presence of B in the BrS measurements gives the
largest likelihood when ILi = B. For any measurement pattern with a single positive, the
case is always classified into that category in this example.
Most predictions are stable with increasing gold-standard percentage, ∆. Only 000
cases have predictions that move from near the center to the corner of A. This is mainly
because that TPR θ and etiology fractions pi are not as precisely estimated in GS-scarce
scenarios relative to GS-abundant ones. Averaging over a wider range of θ and pi produces
000 case predictions that are ambiguous, i.e. near the center. As ∆ increases, parameters
are well estimated, and precise predictions result.
4. Analysis of PERCH data
The Pneumonia Etiology Research for Child Health (PERCH) study is an on-going stan-
dardized and comprehensive evaluation of etiologic agents causing severe and very severe
pneumonia among hospitalized children aged 1-59 months in seven low and middle income
countries (Levine et al., 2012). The study sites include countries with a significant burden
of childhood pneumonia and a range of epidemiologic characteristics. PERCH is a case-
control study that has enrolled over 4, 000 patients hospitalized for severe or very severe
pneumonia and over 5, 000 controls selected randomly from the community frequency-
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matched on age in each month. More details about the PERCH design are available in
Deloria-Knoll et al. (2012).
To analyze PERCH data with the pLCM model, we have focused on preliminary data
from one site with good availability of both SS and BrS laboratory results (no missing-
ness). Final analyses of all 7 countries will be reported elsewhere upon study completion.
Included in the current analysis are BrS data (nasopharyngeal specimen with PCR de-
tection of pathogens) for 432 cases and 479 frequency-matched controls on 11 species of
pathogens (7 viruses and 4 bacteria; representing a subset of pathogens evaluated; their
abbreviations shown on the right margin in Figure 3, and full names in Section B of the
supplementary material), and SS data (blood culture results) on the 4 bacteria for only
the cases.
In PERCH, prior scientific knowledge of measurement error rates is incorporated into
the analysis. Based upon microbiology studies (Murdoch et al., 2012), the PERCH in-
vestigators selected priors for the TPRs of our BrS measurements, θBrSj , in the range of
50%− 100% for viruses and 0− 100% for bacteria. Priors for the SS TPRs were based on
observations from vaccine probe studies—randomized clinical trials of pathogen-specific
vaccines where the total number of clinical pneumonia cases prevented by the vaccine
is much larger than the few SS laboratory-confirmed cases prevented. Comparing the
total preventable disease burden to the number of blood culture (SS) positive cases pre-
vented provides information about the TPR of the bacterial blood culture measurements,
θSSj , j = 1, ..., 4. Our analysis used the range 5−15% for the SS TPRs of the four bacteria
consistent with the vaccine probe studies (Cutts et al., 2005; Madhi et al., 2005). We set
Beta priors that match these ranges (Section 2) and assumed Dirichlet(1, ..., 1) prior on
etiology fractions pi.
In latent variable models like the pLCM, key variables are not directly observed. It
is therefore essential to picture the model inputs and outputs side-by-side to better un-
derstand the analysis. In this spirit, Figure 3 displays for each of the 11 pathogens, a
summary of the BrS and SS data in the left two columns, along with some of the inter-
mediate model results; and the prior and posterior distributions for the etiology fractions
on the right (rows ordered by posterior means). The observed BrS rates (with 95% con-
fidence intervals) for cases and controls are shown on the far left with solid dots. The
conditional odds ratio contrasting the case and control rates given the other pathogens
is listed with 95% confidence interval in the box to the right of the BrS data summary.
Below the case and control observed rates is a horizontal line with a triangle. From left
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to right, the line starts at the estimated false positive rate (FPR, ψˆBrSj ) and ends at the
estimated true positive rate (TPR, θˆBrSj ), both obtained from the model. Below the TPR
are two boxplots summarizing its posterior (top) and prior (bottom) distributions for that
pathogen. These box plots show how the prior assumption influences the TPR estimate
as expected given the identifiability constraints discussed in Section 2.1. The triangle on
the line is the model estimate of the case rate to compare to the observed value above
it. As discussed in Section 2.1, the model-based case rate is a linear combination of the
FPR and TPR with mixing fraction equal to the estimated etiology fraction. Therefore,
the location of the triangle, expressed as a fraction of the distance from the FPR to the
TPR, is the model-based point estimate of the etiologic fraction for each pathogen. The
SS data are shown in a similar fashion to the right of the BrS data. By definition, the
FPR is 0.0% for SS measures and there is no control data. The observed rate for the cases
is shown with its 95% confidence interval. The estimated SS TPR (θˆSSj ) with prior and
posterior distributions is shown as for the BrS data, except that we plot 95% and 50%
credible intervals for SS TPR above its prior 95% and 50% intervals.
On the right side of the display are the marginal posterior and prior distributions of the
etiologic fraction for each pathogen. We appropriately normalized each density to match
the height of the prior and posterior curves. The posterior mean, 50% and 95% credible
intervals are shown above the density.
Figure 3 shows that respiratory syncytial virus (RSV), Streptococcus pneumoniae (PNEU),
rhinovirus (RHINO), and human metapneumovirus (HMPV A B) occupy the greatest
fractions of the etiology distribution, from 15% to 30% each. That RSV has the largest
estimated mean etiology fraction reflects the large discrepancy between case and con-
trol positive rates in the BrS data: 25.1% versus 0.8% (marginal odds ratio 38.5 (95%CI
(18.0, 128.7) ). RHINO has case and control rates that are close to each other, yet its
estimated mean etiology fraction is 16.7%. This is because the model considers the joint
distribution of the pathogens, not the marginal rates. The conditional odds ratio of case
status with RHINO given all the other pathogen measures is estimated to be 1.5 (1.1, 2.1)
as in contrast to the marginal odds ratio close to 1 (0.8, 1.3).
As discussed in Section 2.1, the data alone cannot precisely estimate both the etiologic
fractions and TPRs absent prior knowledge. This is evidenced by comparing the prior and
posterior distributions for the TPRs in the BrS boxes for some pathogens like HMPV A B
and PARA1 (i.e. left hand column of Figure 3). The posteriors are similar to their
priors indicating little else about TPR is learned from the data. The posteriors for some
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pathogens making up pi (i.e. shown in the right hand column of Figure 3) are likely to be
sensitive to the prior specifications of the TPRs.
We performed sensitivity analyses using multiple sets of priors for the TPRs. At one
extreme, we ignored background scientific knowledge and let the priors on the FPR and
TPR be uniform for both the BrS and SS data. Ignoring prior knowledge about error rates
lowers the etiology estimates of the bacteria PNEU and Staphylococcus aureus (SAUR).
The substantial reduction in the etiology fraction for PNEU, for example, is a result of
the difference in the TPR prior for the SS measurements. In the original analysis (Figure
3), the informative prior on the SS sensitivity (TPR) places 95% mass between 5− 15%.
Hence the model assumes almost 90% of the PNEU infections are being missed in the SS
sampling. When a uniform prior is substituted, the fraction assumed missed is greatly
reduced. For RSV, its posterior mean etiology fraction is stable (29.4% to 30.0%). The
etiology estimates for other pathogens are fairly stable, with changes in posterior means
between −2.3% and 3.4%.
Under the original priors for TPR, PARA1 has an estimated etiologic fraction of 6.4%,
even though it has conditional odds ratio 5.9 (2.6, 15.0). In general, pathogens with larger
conditional odds ratios have larger etiology fraction estimates. But a pathogen also needs
a reasonably high observed case positive rate to be allocated a high etiology fraction. The
posterior etiology fraction estimate of 6.4% for PARA1 results because the prior for the
TPR takes values in the range of 50 − 99%. By Equation (6), the TPR weight in the
convex combination with FPR (around 1.5%) has to be very small to explain the small
observed case rate 5.6%. When a uniform prior is placed on TPR instead, the PARA1
etiology fraction increases to 9.4% with a wider 95% credible interval.
We believe that RHINO’s etiologic fraction may be inflated as a result of its negative
association with RSV among cases. Under the conditional independence assumption of
the pLCM, this dependence can only be explained by multinomial correlation among the
latent cause indicators: ILi = RSV versus I
L
i = RHINO that is −piRSVpiRHINO. There is
strong evidence that RSV is a common cause with a stable estimate pˆiRSV around 30%.
The strong negative association in the cases’ measurements between RHINO and RSV
therefore is being explained by a larger etiologic fraction estimate pˆiRHINO relative to
other pathogens that have less or no association with RSV among the cases. The condi-
tional independence assumption is leveraging information from the associations between
pathogens in estimation of the etiologic fractions. If true, this issue can be addressed by
extending the pLCM to allow for alternate sources of correlation among the measurements,
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for example, competition among pathogens within the NP space.
We have checked the model in two ways by comparing the characteristics of the observed
measurements joint distribution with the same characteristic for the distribution of data
of the same size generated by the model. By generating the new data characteristics at
every iteration of the MCMC chain, we can obtain the posterior predictive distribution by
integrating over the posterior distribution of the parameters (Garrett and Zeger, 2000).
Among the cases, the 95% predictive interval includes the observed values in all but
two of the BrS patterns and even there the fits are reasonable. Among the controls, there
is evidence of lack of fit for the most common BrS pattern with only PNEU and HINF
(Figure S1 in supplementary materials). There are fewer cases with this pattern observed
than predicted under the pLCM. This lack of fit is likely due to associations of pathogen
measurements in control subjects. Note that the FPR estimates remain consistent regard-
less of such correlation as the number of controls increases, however posterior variances
for them may be underestimated.
A second model-checking procedure is for the conditional independence assumption.
We estimated standardized log odds ratios (SLORs) for cases and controls (see Figure
S2 in supplementary materials). Each value is the observed log odds ratio for a pair of
BrS measurements minus the mean LOR from the posterior predictive distribution value,
under the model’s independence assumption, divided by the standard deviation of the
same posterior predictive distribution. We find two large deviations among the cases:
RSV with RHINO and RSV with HMPV. These are likely caused by strong seasonality in
RSV that is out of phase with weaker seasonality in the other two. Otherwise, the number
of SLOR’s greater than 2 (8 out of 110) associations is only slightly larger than what is
expected under the assumed model (6 expected).
An attractive feature of using MCMC to estimate posterior distributions is the ease
of estimating posteriors for functions of the latent variables and/or parameters. One in-
teresting question from a clinical perspective is whether viruses or bacteria are the major
cause and among each subgroup, which species predominate. Figure 4 shows the pos-
terior distribution for the rate of viral pneumonia on the top, and then the conditional
distributions of the two leading viruses (bacteria) among viral (bacterial) causes below on
the right (left). The posterior distribution of the viral etiologic fraction has mode around
70.0% with 95% credible interval (57.0%, 79.2%). As shown at the bottom left in Figure 4,
PNEU accounts for most bacterial cases (47.2% (24.9%, 71.1%)), and SAUR accounts for
25.5% (8.7%, 49.9%). Of all viral cases (bottom right), RSV is estimated to cause about
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42.9% (32.8%, 54.8%), and RHINO about 24.2% (13.7%, 37.2%).
5. Discussion
In this paper, we estimated the frequency with which pathogens cause disease in a case
population using a partially-latent class model (pLCM) to allow for known states for
a subset of subjects and for multiple types of measurements with different error rates.
In a case-control study of disease etiology, measurement error will bias estimates from
traditional logistic regression and attributable fraction methods. The pLCM avoids this
pitfall and more naturally incorporates multiple sources of data. Here we formulated the
model with three levels of measurement error rates.
Absent GS data, we show that the pLCM is only partially identified because of the
relationship between the estimated TPR and prevalence of the associated pathogen in the
population. Therefore, the inferences are sensitive to the assumptions about the TPR.
Uncertainty about their values persists in the final inferences from the pLCM regardless
of the number of subjects studied.
The current model provides a novel solution to the analytic problems raised by the
PERCH Study. This paper introduces and applies pLCM to a preliminary set of data
from one PERCH study site. Confirmatory laboratory testing, incorporation of additional
pathogens, and adjustment for potential confounders may change the scientific findings
that will be reported the final complete analysis of the study results when it is completed.
An essential assumption relied upon in the pLCM is that the probability of detecting
one pathogen at a peripheral body site depends on whether that pathogen is infecting
the child’s lung, but is unaffected by the presence of other pathogens in the lung, that is,
the non-differential misclassification error assumption. We have formulated the model to
include GS measures even though they are available only for a small and unrepresentative
subset of the PERCH cases. In general, the availability of GS measures makes it possible
to test this assumption as has been discussed by Albert and Dodd (2008).
Several extensions have potential to improve the quality of inferences drawn and are
being developed for PERCH. First, because the control subjects have known class, we
can model the dependence structure among the BrS measurements and use this to avoid
aspects of the conditional independence assumption central to most LCM methods. The
approach is to extend the pLCM to have K subclasses within each of the current disease
classes. These subclasses can introduce correlation among the BrS measurements given
the true disease state. An interesting question is about the bias-variance trade-off for
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different values of K. This ideas follows previous work on the PARAFAC decomposition
of probability distribution for multivariate categorical data (Dunson and Xing, 2009). This
extension will enable model-based checking of the standard pLCM.
Second, in our analyses to date, we have assumed that the pneumonia case definition
is error-free. Given new biomarkers and availability of chest radiographs that can improve
upon the clinical diagnosis of pneumonia, one can introduce an additional latent variable
to indicate true disease status and use these measurements to probabilistically assign each
subject as a case or control. Finally, regression extensions of the pLCM would allow
PERCH investigators to study how the etiology distributions vary with HIV status, age
group, and season.
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A. Full conditional distributions in Gibbs sampler
In this section, we provide analytic forms of full conditional distributions that are es-
sential for Gibbs sampling algorithm. We use data augmentation scheme by introducing
latent lung state ILi into the sampling chain and we have the following full conditional
distributions:
• [ILi | others]. If MGSi is available, Pr (ILi = j | others) = 1, if MGSij = 1 and MGSil =
0, for l 6= j; otherwise zero. If MGSi is missing, according as whether MSSi is available,
the full conditional is given as
Pr(ILi = j | others) ∝
(
θBrSj
)MBrSij (1− θBrSj )1−MBrSij ∏
l 6=j
(
ψBrSl
)MBrSil (1− ψBrSl )1−MBrSil
·
[(
θSSj
)MSSij (1− θSSj )1−MSSij 1{∑l6=jMSSil =0}
]1{j≤J′}
· pij ; (8)
if SS measurement is not available for case i, we remove terms involving MSSij .
•
[
ψBrSj | others
]
∼ Beta (Nj + b1j , n1 −∑i:Yi=1 1{ILi =j} + n0 −Nj + b2j), where n1
and n0 are number of cases and controls, respectively, and Nj =
∑
i:Yi=1,ILi 6=jM
BrS
ij +∑
i:Yi=0
MBrSij is the number of positives at position j for cases with I
L
i 6= j and all
controls.
•
[
θBrSj | others
]
∼ Beta (Sj + c1j ,∑i:Yi=1 1{ILi =j} − Sj + c2j), where Sj = ∑i:Yi=1,ILi =jMBrSij
is the number of positives for cases with jth pathogen as their causes.
•
[
θSSj | others
]
∼ Beta
(
Tj + d1j ,
∑
i:Yi=1,SS available 1{ILi =j} − Tj + d2j
)
, where Tj =∑
i:Yi=1,ILi =j,SS available
MSSij . When no SS data is available, this conditional distribu-
tion reduces to Beta(d1j , d2j), the prior.
• [pi | ILi , i : Yi = 1] ∼ Dirichlet(a1 + U1, ..., aJ + UJ), where Uj = ∑i:Yi=1 1{ILi =j}.
B. Pathogen names and their abbreviations
Bacteria: HINF- Haemophilus influenzae; PNEU-Streptococcus pneumoniae; SASP-Salmonella
species; SAUR-Staphylococcus aureus. Viruses: ADENO-adenovirus; COR 43-coronavirus
OC43; FLU C-influenza virus type C; HMPV A B-human metapneumovirus type A or B;
PARA1-parainfluenza type 1 virus; RHINO-rhonovirus; RSV A B-respiratory syncytial
virus type A or B.
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Fig. 1: Directed acyclic graph (DAG) illustrating relationships among lung infection state
(IL), imperfect lab measurements on the presence/absence of each of a list of pathogens
at each site(MNP , MB and ML), disease outcome (Y ), and covariates (X).
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Fig. 2: Population (top) and individual (bottom) etiology estimations for a single sample
with 500 cases and 500 controls with true pi = (0.67, 0.26, 0.07)′ and either 1%(N = 5) or
10%(N = 50) GS data on cases. In (a) or (b), red circled plus shows the true population
etiology distribution pi. The closed curves are 95% credible regions for analysis using
BrS data only (blue dashed lines “- - -”), BrS+GS data (light green solid lines “—”), GS
data only (textitblack dotted lines “· · · ”); Solid square/dot/triangle are the corresponding
posterior means of pi; The 95% highest density region of uniform prior distribution is
also visualized by red “· − ·−” for comparison. In (c) or (d), 8(= 23) BrS measurement
patterns and predictions for individual children are shown with measurement patterns
attached. The numbers at the vertices show empirical frequencies of GS measurements.
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Fig. 3: The observed BrS rates (with 95% confidence intervals) for cases and controls are
shown on the far left. The conditional odds ratio given the other pathogens is listed with
95% confidence interval in the box to the right of the BrS data summary. In the left box,
below the case and control observed rates is a horizontal line with a triangle. The line
starts on the left at the model estimated false positive rate (FPR, ψˆBrSj ) and ends on the
right at the estimated true positive rate (TPR, θˆBrSj ). Below the TPR are two boxplots
summarizing its posterior (top) and prior (bottom) distributions. The location of the
triangle, expressed as a fraction of the distance from the estimated FPR to the TPR, is
the point estimate of the etiologic fraction for each pathogen. The SS data are shown in a
similar fashion to the right of the BrS data using support intervals rather than boxplots.
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Fig. 4: Summary of posterior distribution of pneumonia etiology estimates. Top: posterior
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two causes given a bacterial (viral) infection. The blue circles are the 95% credible regions
within the bacterial or viral groups.
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Fig. S1: Posterior predictive checking for 10 most frequent BrS measurement patterns
among cases and controls with expert priors on TPRs.
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Fig. S2: Posterior predictive checking for pairwise odds ratios separately for cases (lower
triangle) and controls (upper triangle) with expert priors on TPRs. Each entry is a
standardized log odds ratio (SLOR): the observed log odds ratio for a pair of BrS mea-
surements minus the mean LOR for the posterior predictive distribution divided by the
standard deviation of the posterior predictive distribution. The first significant digit of
absolute SLORs are shown in red for positive and blue for negative values, and only those
greater than 2 are shown.
